Tutticci Nicholas, Klein Amir, Sonson Rebecca, Bourke Michael J
Department of Gastroenterology and Hepatology, Westmead Hospital, Sydney, Australia.
Endoscopy. 2016 May;48(5):465-71. doi: 10.1055/s-0042-101854. Epub 2016 Mar 23.
Endoscopic mucosal resection (EMR) is an established treatment for large (≥ 20 mm) laterally spreading lesions (LSLs). LSLs with complete or subtotal (> 90 %) circumferential extent (C-LSLs) are generally referred for surgery. Data on technique, efficacy, and safety of EMR for these lesions are absent. The aim of this study was to describe the technique and long-term outcomes of EMR for C-LSLs.
Prospective observational study of consecutive patients referred for EMR of LSL at a tertiary care center over 63 months to April 2015. Amongst 979 patients with LSL, 12 patients with C-LSL were seen.
All lesions were tubulovillous adenomas with granular 0 - IIa + Is morphology. Median longitudinal extent was 95 mm (range 60 - 160), 58 % were located in the rectum, and 3 lesions (25 %) had complete circumferential involvement. EMR technical success was 100 %. There were no major adverse events. Symptomatic stricturing occurred in 2 cases (17 %) and was treated with endoscopic balloon dilation (median 4 sessions). Median follow up is 13 months. Minor residual adenoma was found in 7 (58 %) at first surveillance colonoscopy and was treated with snare excision. A total of 10 patients have completed a second surveillance colonoscopy with minor residual adenoma found in only 1 case. No patient required surgery or developed cancer in long-term follow-up.
Endoscopic resection of C-LSL is feasible and safe. Minor residual adenoma is common but endoscopically treatable with long-term cure. Symptomatic stricturing amenable to balloon dilation may occur. Empiric surgical referral for C-LSL based on extensive circumferential involvement may be avoided.ClinicalTrials.gov NCT01368289.
内镜黏膜切除术(EMR)是治疗大的(≥20mm)侧向发育型病变(LSL)的既定方法。具有完全或大部分(>90%)周向范围的LSL(C-LSL)通常需接受手术治疗。目前尚无关于EMR治疗这些病变的技术、疗效和安全性的数据。本研究的目的是描述EMR治疗C-LSL的技术及长期结果。
对一家三级医疗中心在至2015年4月的63个月期间连续接受LSL EMR治疗的患者进行前瞻性观察研究。在979例LSL患者中,发现12例C-LSL患者。
所有病变均为具有颗粒状0-IIa+Is形态的管状绒毛状腺瘤。纵向范围的中位数为95mm(范围60-160),58%位于直肠,3例病变(25%)有完全周向累及。EMR技术成功率为100%。无重大不良事件。2例(17%)出现症状性狭窄,经内镜球囊扩张治疗(中位数4次)。中位随访时间为13个月。首次结肠镜监测时,7例(58%)发现微小残留腺瘤,经圈套切除治疗。共有10例患者完成了第二次结肠镜监测,仅1例发现微小残留腺瘤。长期随访中无患者需要手术或发生癌症。
内镜切除C-LSL是可行且安全的。微小残留腺瘤常见,但可通过内镜治疗实现长期治愈。可能会出现适合球囊扩张治疗的症状性狭窄。基于广泛周向累及而对C-LSL进行经验性手术转诊可避免。ClinicalTrials.gov NCT01368289 。